Chembio Diagnostics (CEMI) Cash Flow Statement

Click line-items for a historical chart and %

Cash received from customers and grants	11.93M
Cash paid to suppliers and employees	-17.61M
Interest received	9.73K
Interest paid	0
Net cash provided by (used in) operating activities
Acquisition of and deposits on fixed assets
Net cash used in investing activities
Proceeds from option and warrant exercises	57.58K
Payment of license obligation
(Payment of) and Proceeds from loan obligation, net
Payment of capital lease obligation
Net cash provided by (used in) financing activities
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	6.8M
Cash and cash equivalents - beginning of the period	5.38M
Cash and cash equivalents - end of the period	12.17M
Net Income	-10.79M
Depreciation and amortization	876.1K
Provision for doubtful accounts
Share based compensation	220.27K
Accounts receivable	-1.79M
Inventories	150.87K
Prepaid expenses and other current assets	-37.63K
Deposits and other assets	1.48K
Accounts payable and accrued liabilities	-213.04K
Deferred research and development revenue
Net cash provided by (used in) operating activities
Deposits on manufacturing equipment transferred to fixed assets	49.59K

Entities mentioned with CEMI

View All Entities